معرفی
Milo White, MD is a Research Fellow at the Yale School of Medicine, Yale University. His primary affiliation is Yale School of Medicine, where he focuses on diabetes and metabolic research. He completed his MD at the University of Utah School of Medicine (2020) and holds a board certification in Neurology from the American Board of Psychiatry and Neurology (2024).
Dr. White’s research interests are centered on insulin signaling pathways, metabolic disorders, and endocrinology. His work explores mechanisms governing glucose homeostasis, hepatic metabolism, and the molecular underpinnings of diabetes. Specific areas include BRD7’s role in glucose regulation, MTOR signaling in metabolic dysfunction, and hepatokine functions in non-alcoholic fatty liver disease (NAFLD).
His recent studies investigate how follistatin influences type 2 diabetes risk and how TAZ transcription factors modulate glucocorticoid receptor activity in liver cells. He has also contributed to understanding insulin receptor substrate (IRS) protein dynamics and their implications in metabolic diseases.
Dr. White’s publications span over 200 articles, emphasizing translational research bridging molecular biology and clinical outcomes. His work frequently involves collaborations with institutions like the German Diabetes Center and the Broad Institute, reflecting a focus on interdisciplinary metabolic research.
No awards or grants are explicitly listed in the provided materials. His current research is likely supported through institutional grants or collaborative funding.